Kate Poss meets her mark…and then some!
Starting out with a goal of $2,620 (100 for every mile she ran, “plus an extra $20 for that pesky last .2 mile”), Kate exceeded it within six hours. Kate then raised her goal to [...]
Starting out with a goal of $2,620 (100 for every mile she ran, “plus an extra $20 for that pesky last .2 mile”), Kate exceeded it within six hours. Kate then raised her goal to [...]
By Belinda Ehrlich, LRG Program Associate & Erin Kristoff, Newsletter Editor And the winner is... After careful consideration, the Life Raft Group has chosen the recipient of the GIST Clinician of the Year award – Dr. [...]
When Morty Wagman underwent surgery to remove a gastrointestinal stromal tumour (GIST) in 2008 with his wife Judi by his side, he was faced with a concerning 55 percent chance that his cancer would return. Then, his oncologist told him about Gleevec (imatinib), a treatment that could greatly reduce the risk of his cancer returning, and Wagman felt empowered and hopeful. Today, he and his wife applaud Health Canada for approving Gleevec for patients with this potentially life-threatening condition, at an earlier stage in the disease.
Here, you can register for Life Fest, view pictures, video and presentations from past Life Fests, download a nomination form for GIST Clinician of the Year and download materials for our new project: Tree of Life.
Innovative project will allow GIST researchers worldwide to access GIST tissue linked to patient-provided clinical histories. For more information on the GIST Tissue bank read the official press release.
Dr. Chris CorlessKnight Cancer InstitutePortland, Oregon For a patient suddenly faced with a cancer diagnosis, the process by which the diagnosis was made may seem of little interest. It is only the [...]
Life Fest 2008 was a wonderful event. A big thanks to everyone who attended for making the event such a success.
The legal battle that had been waged by the Abigail Alliance since 2003 ended abruptly on January 14 when the Supreme Court refused to hear the appeal by the patient advocates. Currently, it is illegal [...]
This is part one of a two-part series on “KIT and PDGFRA kinase mutations in GIST: from A to Z”. In this newsletter, Dr. Heinrich will provide a background on the role of kinase mutations in GIST, focusing largely on the biological and clinical implications of these mutations. In part two (which will be featured in the July 2007 edition of the newsletter, following the special “Five-year anniversary” edition),